Core Viewpoint - Tianjin Tasly Pharmaceutical has withdrawn its application for the registration of Loquat Lung Cleansing Granules due to the need for further improvement of the application materials [1] Group 1: Company Actions - The company submitted the drug registration application to the National Medical Products Administration in January 2024 and received acceptance [1] - The company has submitted a request to withdraw the drug registration application and has received a notification from the National Medical Products Administration agreeing to the withdrawal [1] - The total R&D investment for this project amounts to 11.3662 million yuan [1] Group 2: Impact on Operations - The withdrawal of the application is not expected to have a significant impact on the company's current and future production operations and performance [1] - The pharmaceutical industry is characterized by high technology and high risk, with long R&D cycles and multiple influencing factors [1]